Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Spelman

Showing results (161-170 of 266) with videos related to

Pageof 27
Sort By:
Plos One|August 13, 2013
Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settingsCatherine S Marshall, Andrea J Curtis, Tim Spelman, et al.
Plos One|August 21, 2012
Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individualsShuo Li, Stuart Roberts, Magdalena Plebanski, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2016
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched studyIlya Kister, Tim Spelman, Raed Alroughani, et al.
Plos One|November 19, 2013
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort studyRachel Sacks-Davis, Campbell K Aitken, Peter Higgs, et al.
Medicine|February 22, 2020
Trends in late and advanced HIV diagnoses among migrants in Australia; implications for progress on Fast-Track targets: A retrospective observational studyTafireyi Marukutira, Praveena Gunaratnam, Caitlin Douglass, et al.
The Journal of Clinical Psychiatry|August 3, 2022
Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label TrialMaximus Berger, Emily Li, Simon Rice, et al.
The American Journal of Tropical Medicine and Hygiene|January 21, 2016
Therapeutic Potential of Tea Tree Oil for ScabiesJackson Thomas, Christine F Carson, Greg M Peterson, et al.
Plos One|September 22, 2011
SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humansClare F Price, David Tyssen, Secondo Sonza, et al.
Journal of Medical Imaging and Radiation Oncology|February 12, 2020
Accuracy of non-contrast quiescent-interval single-shot and quiescent-interval single-shot arterial spin-labelled magnetic resonance angiography in assessment of peripheral arterial disease in a diabetic populationAdrienne Lam, Yuliya Perchyonok, Dinesh Ranatunga, et al.
JTO Clinical and Research Reports|February 2, 2026
Treatment Patterns, Prognostic Factors and Survival for ALK-Positive Advanced NSCLC In Australia: Results From the Australasian Thoracic Cancers Longitudinal Cohort Study and Biobank (AURORA)Grace Chazan, Marliese Alexander, Fanny Franchini, et al.
Pageof 27

Showing results (161-170 of 266) with videos related to

Sort By:
Pageof 27
Plos One|August 13, 2013
Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settingsCatherine S Marshall, Andrea J Curtis, Tim Spelman, et al.
Plos One|August 21, 2012
Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individualsShuo Li, Stuart Roberts, Magdalena Plebanski, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2016
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched studyIlya Kister, Tim Spelman, Raed Alroughani, et al.
Plos One|November 19, 2013
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort studyRachel Sacks-Davis, Campbell K Aitken, Peter Higgs, et al.
Medicine|February 22, 2020
Trends in late and advanced HIV diagnoses among migrants in Australia; implications for progress on Fast-Track targets: A retrospective observational studyTafireyi Marukutira, Praveena Gunaratnam, Caitlin Douglass, et al.
The Journal of Clinical Psychiatry|August 3, 2022
Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label TrialMaximus Berger, Emily Li, Simon Rice, et al.
The American Journal of Tropical Medicine and Hygiene|January 21, 2016
Therapeutic Potential of Tea Tree Oil for ScabiesJackson Thomas, Christine F Carson, Greg M Peterson, et al.
Plos One|September 22, 2011
SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humansClare F Price, David Tyssen, Secondo Sonza, et al.
Journal of Medical Imaging and Radiation Oncology|February 12, 2020
Accuracy of non-contrast quiescent-interval single-shot and quiescent-interval single-shot arterial spin-labelled magnetic resonance angiography in assessment of peripheral arterial disease in a diabetic populationAdrienne Lam, Yuliya Perchyonok, Dinesh Ranatunga, et al.
JTO Clinical and Research Reports|February 2, 2026
Treatment Patterns, Prognostic Factors and Survival for ALK-Positive Advanced NSCLC In Australia: Results From the Australasian Thoracic Cancers Longitudinal Cohort Study and Biobank (AURORA)Grace Chazan, Marliese Alexander, Fanny Franchini, et al.
Pageof 27